Research theme for competitive and other funds (3):
2015 - 2018 統合失調症発症の脳病態解明と発症予測因子の同定
2012 - 2014 統合失調症発症の脳病態解明と発症予測因子の同定
2010 - 2012 統合失調症発症の脳病態解明と発症予測因子の同定
Papers (87):
Yukako Watanabe, Sho Kanata, Motomu Suga, Akiko Inagaki, Sayaka Sato, Naoki Hayashi, Hiroshi Kunugi, Emi Ikebuchi. Characteristic association of symbol coding test score with occupational function in Japanese patients with schizophrenia. Neuropsychopharmacology Reports. 2023. 43. 1. 141-145
Kenji Kirihara, Mao Fujioka, Motomu Suga, Shinsuke Kondo, Kayo Ichihashi, Daisuke Koshiyama, Kentaro Morita, Tempei Ikegame, Mariko Tada, Tsuyoshi Araki, et al. Betaine supplementation improves positive symptoms in schizophrenia. Schizophrenia research. 2022. 250. 120-122
Kaori Usui, Kenji Kirihara, Mariko Tada, Mao Fujioka, Daisuke Koshiyama, Motoko Tani, Maiko Tsuchiya, Susumu Morita, Shintaro Kawakami, Akiko Kanehara, et al. The association between clinical symptoms and later subjective quality of life in individuals with ultra-high risk for psychosis and recent-onset psychotic disorder: A longitudinal investigation. Psychiatry and clinical neurosciences. 2022